Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-280

Cheers for your input Dplane.

In the likelihood of an absence of news between now and ahead of upcoming CHF meeting, the August PDUFA date and the beginning of the CLBP trial I believe this discussion should continue as it is relevant to every single investor.

I agree that a lot of these posts are likely paid. If it's not paid, it's FUD & shorting.

Not to mention if they are shorting, to quote another poster that apparentlyis not giving financial advice, "hopefully something can get a bit of a tailwind [for the shorters] so they can at least claw back some of their losses".

Too much time and effort has been invested into these posts that there has to be some sort of incentive other than "truth seeking". People who are truly "truth seekers" regarding health and medicine do not fixate in a single product that they believe doesn't work. They leave it for the FDA to decide.

Much less so on a forum specifically for investors.